Private investors in Asia, including family offices operating in Hong Kong, are showing a growing appetite for advanced medical technologies such as brain-computer interfaces and surgical robotics, as healthcare deal activity picks up across the region amid China’s biotechnology boom. “Asia is ageing, so there’s a structural, long-term demand for better surgery and medicine,” said William Chow, deputy group CEO of Raffles Family Office, headquartered in Hong Kong and Singapore. “A lot of the...